Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | SPOP | O43791 | 11/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | APAF1 | O14727 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12374918 | 1.00 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL7770365 | 1.00 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL1131848 | 1.00 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL1131847 | 1.00 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL5592457 | 1.00 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| Hydrochloric Acid SCHEMBL9483729 | 0.99 | TDP1 (0.54) | TDP1MAPTPOLBPKMHTT | |
| Hydrochloric Acid SCHEMBL9483725 | 0.99 | TDP1 (0.54) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL1132036 | 0.88 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL1132035 | 0.88 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT | |
| SCHEMBL1132808 | 0.88 | TDP1 (0.55) | TDP1MAPTPOLBPKMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118706995-A | Analysis method and application of cefdinir intermediate medium control reaction liquid | 湖北凌晟药业股份有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118688349-A | Analysis method of cefdinir and cefixime mother nucleus and related impurities | 湖北凌晟药业股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-117924319-B | Method for removing cefixime polymer impurities and method for preparing cefixime | 广药白云山化学制药(珠海)有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-117924319-A | Method for removing cefixime polymer impurities and method for preparing cefixime | 广药白云山化学制药(珠海)有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-113429283-B | Method for recovering phenylacetic acid from medical wastewater | 湖北凌晟药业有限公司 | 2022-04-22 | — | — | CN | claimed |
| WO-2007008672-A1 | CRYSTALLINE CEFDINIR TRIHEMIHYDRATE | ABBOTT LABORATORIES (US) | 2007-01-18 | — | — | WO | claimed |
| US-20060287289-A1 | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates | ABBOTT LABORATORIES | 2006-12-21 | — | — | US | claimed |
| US-20060211676-A1 | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates | ABBOTT LABORATORIES | 2006-09-21 | — | — | US | claimed |
| CN-118706995-A | Analysis method and application of cefdinir intermediate medium control reaction liquid | 湖北凌晟药业股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118706995-A | Analysis method and application of cefdinir intermediate medium control reaction liquid | 湖北凌晟药业股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118688349-A | Analysis method of cefdinir and cefixime mother nucleus and related impurities | 湖北凌晟药业股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118688349-A | Analysis method of cefdinir and cefixime mother nucleus and related impurities | 湖北凌晟药业股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-117924319-B | Method for removing cefixime polymer impurities and method for preparing cefixime | 广药白云山化学制药(珠海)有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-117924319-B | Method for removing cefixime polymer impurities and method for preparing cefixime | 广药白云山化学制药(珠海)有限公司 | 2024-08-27 | — | — | CN | disclosed |
| EP-0854875-B1 | NEW CEPHEM COMPOUNDS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-06-13 | — | — | EP | disclosed |
| US-6159961-A | Cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-12 | — | — | US | disclosed |
| US-5958914-A | FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-28 | — | — | US | disclosed |
| EP-0854875-A1 | NEW CEPHEM COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997012890-A1 | NEW CEPHEM COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-10 | — | — | WO | disclosed |
| EP-0280521-A2 | Cephalosporin compounds, process for their preparation and pharmaceutical compositions containing them | GLAXO GROUP LIMITED (GB) | 1988-08-31 | — | — | EP | disclosed |